Advertisement

Closed system anaesthesia in dogs using liquid sevoflurane injection; evaluation of the square-root-of-time model and the influence of CO2 absorbent

      Abstract

      Objective

      To determine whether predictable alveolar concentrations of sevoflurane are reliably produced in dogs when liquid sevoflurane is injected into closed circuit breathing systems, as calculated by Lowe's square-root-of-time anaesthetic uptake model, and to confirm the validity of the model using soda lime and calcium hydroxide lime.

      Study design

      Prospective clinical study.

      Animals

      Eleven healthy dogs with a mean body mass of 34 ± 9 kg scheduled for pelvic limb orthopaedic surgery.

      Materials and methods

      Following pre-anaesthetic medication, anaesthesia was induced with propofol and maintained with sevoflurane in a closed circle system. Epidural anaesthesia was performed with morphine and bupivacaine. Liquid sevoflurane was injected into the circuit by syringe, using dosages and time intervals derived from Lowe's square-root-of-time anaesthetic uptake model. The target alveolar concentration chosen was 1.1 × MAC (2.6% end-tidal sevoflurane). Either soda lime (group S; n = 6) or calcium hydroxide lime (Amsorb; group A; n = 5) were used for CO2 absorption. Sevoflurane concentration and the respiratory gas composition were measured with an infrared gas analyser.

      Results

      End-tidal sevoflurane concentrations were close to the predicted value of 2.6% at 9 minutes (2.53 ± 0.1% group S; 2.60 ± 0.26% group A) and 16 minutes (2.55 ± 0.30 group S; 2.52 ± 0.28% group A) but declined thereafter to reach 50% (group S) and 64% (group A) of the predicted value at 121 minutes. There was a constant trend towards higher end-tidal sevoflurane concentrations in group A but the difference was not statistically significant.

      Conclusions

      The square-root-of-time model leads to significantly lower alveolar concentrations than expected, suggesting that the rate of sevoflurane uptake in dogs declines less rapidly than predicted. The use of Amsorb tends to reduce the deviation from predicted concentrations.

      Clinical relevance

      The model used in this study provided only an approximate guide to the volume of liquid sevoflurane required. Consequently, the definitive dose schedule must be based on measured anaesthetic concentrations and clinical monitoring.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Veterinary Anaesthesia and Analgesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Vorteile der Rückatmung.
        in: Baum J Die Inhalationsanästhesie mit niedrigem Frischgasfluss. 3rd edn. Thieme, Stuttgart1998: 62-75 (1991)
        • Bengtson JP
        • Bengtsson A
        • Stenqvist O
        Uptake of enflurane and isoflurane during spontaneous and controlled ventilation.
        Anaesth Intens Care. 1992; 20: 191-195
        • Bengtson JP
        • Bengtsson A
        • Stenqvist O
        Nitrous oxide uptake during spontaneous and controlled ventilation.
        Anaesthesia. 1994; 49: 25-28
        • Bito H
        • Ikeda K
        Closed-circuit anesthesia with sevoflurane in humans.
        Anesthesiology. 1994; 80: 71-76
        • Bito H
        • Ikeuchi Y
        • Ikeda K
        Effects of low-flow sevoflurane anesthesia on renal function.
        Anesthesiology. 1997; 86: 1231-1237
        • Boller M
        • Gootjes P
        • Kästner SBR
        • et al.
        Pitfalls in using modern gas analysers for monitoring closed-system anaesthesia.
        Vet Anaesth Analg. 2001; 28 (Abstract).: 208-209
        • Brody S
        Bioenergetics and growth. Reinhold, New York, USA.1945
        • Couto da Silva JM
        • Mapleson WW
        • Vickers MD
        Quantitative study of Lowe's square-root-of-time method of closed system anaesthesia.
        Br J Anaesth. 1997; 79: 103-112
        • Cunningham DD
        • Huang S
        • Webster J
        • et al.
        Sevoflurane degradation to compound A in anaesthesia breathing systems.
        Br J Anaesth. 1996; 77: 537-543
        • Dorsch JA
        • Dorsch SE
        Understanding Anesthesia Equipment. 4th edn. Williams & Wilkins, Baltimore1999: 557-671
        • Eger EI
        Complexities overlooked: things may not be what they seem.
        Anesth Analg. 1997; 84: 239-240
        • Eger EI
        Uptake and distribution.
        in: Miller RD Anesthesia. 5th edn. Churchill Livingstone, Philadelphia, PA, USA2000: 74-95
        • Eger EI
        • Koblin DD
        • Bowland T
        • et al.
        Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers.
        Anesth Analg. 1997; 84: 160-168
        • Eger EI
        • Ionescu P
        • Gong D
        Circuit absorption of halothane, isoflurane, and sevoflurane.
        Anesth Analg. 1998; 86: 1070-1074
        • Groudine SB
        • Fragen RJ
        • Kharasch ED
        • et al.
        Comparison of renal function following anesthesia with low-flow sevoflurane and isoflurane.
        J Clin Anesth. 1999; 11: 201-207
        • Hendrickx JFA
        • Soetens M
        • Van der Donck A
        • et al.
        Uptake of desflurane and isoflurane during closed-circuit anesthesia with spontaneous and controlled mechanical ventilation.
        Anesth Analg. 1997; 84: 413-418
        • Hendrickx JFA
        • Van Zundert AAJ
        • De Wolf AM
        Sevoflurane pharmacokinetics: effects of cardiac output.
        Br J Anaesth. 1998; 81: 495-501
        • Hendrickx JFA
        • Van Zundert AAJ
        • De Wolf AM
        Influence of the reference gas of paramagnetic oxygen analysers on nitrogen concentrations during closed-circuit anesthesia.
        J Clin Monit. 1998; 14: 381-384
        • Higuchi H
        • Adachi Y
        • Arimura S
        • et al.
        Compound A concentrations during low-flow sevoflurane anesthesia correlate directly with the concentrations of monovalent bases in carbon dioxide absorbents.
        Anesth Analg. 2000; 91: 434-439
        • Higuchi H
        • Adachi Y
        • Wada H
        • et al.
        The effects of low-flow sevoflurane and isoflurane anesthesia on renal function in subjects with stable moderate renal insufficiency.
        Anesth Analg. 2001; 92: 650-655
        • Kazama T
        • Ikeda K
        Comparison of MAC and the rate of rise of alveolar concentration of sevoflurane with halothane and isoflurane in the dog.
        Anesthesiology. 1988; 68: 435-437
        • Kharasch ED
        Biotransformation of sevoflurane.
        Anesth Analg. 1995; 81: S27-S38
        • Kharasch ED
        • Frink EJ
        • Artru A
        • et al.
        Long-duration low-flow sevoflurane and isoflurane effects on postoperative renal and hepatic function.
        Anesth Analg. 2001; 93: 1511-1520
        • Kharasch ED
        • Powers KM
        • Artu AA
        Comparison of Amsorb, sodalime and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound A in swine in vivo.
        Anesthesiology. 2002; 96: 173-182
        • Laster MJ
        • Taheri S
        • Eger EI
        • et al.
        Visceral losses of desflurane, isoflurane, and halothane in swine.
        Anesth Analg. 1991; 73: 209-212
        • Lin CY
        Uptake of anaesthetic gases and vapours.
        Anaesth Intens Care. 1994; 22: 363-373
        • Lin CY
        • Yang MW
        Uptake of inhalation anesthetics does not follow a power function.
        Anesthesiology. 1997; 87 (Abstract).: 345
        • Lowe HJ
        • Ernst EA
        The Quantitative Practice of Anesthesia. 1st edn. Williams & Wilkins, Baltimore, MD, USA1981
        • Lowe HJ
        • Viljoen JF
        Nomogram for anaesthetic uptake.
        Anaesth Intens Care. 1994; 22: 374-375
        • Lowe D
        • Hettrick DA
        • Pagel PS
        • et al.
        Influence of volatile anesthetics on left ventricular afterload in vivo.
        Anesthesiology. 1996; 85: 112-120
      2. Oxygen.
        in: Lumb AB Nunn's Applied Respiratory Physiology. 5th edn. Butterworth Heinemann, Oxford, UK2000: 249-305
        • Mazze RI
        • Callan CM
        • Galves ST
        • et al.
        The effects of sevoflurane on serum creatinine and blood urea nitrogen concentration: a retrospective, twenty-two-center, comparative evaluation of renal function in adult surgical subjects.
        Anesth Analg. 2000; 90: 683-688
        • Moens Y
        Introduction to the quantitative technique of closed circuit anesthesia in dogs.
        Vet Surg. 1988; 17: 98-104
        • Morio M
        • Fuji K
        • Satoh N
        • et al.
        Reaction of sevoflurane and its degradation products with soda lime.
        Anesthesiology. 1992; 77: 1155-1164
        • Morita S
        • Latta W
        • Hambro K
        • et al.
        Accumulation of methane, acetone, and nitrogen in the inspired gas during closed-circuit anesthesia.
        Anesth Analg. 1985; 64: 343-347
        • Muir WW
        • Gadawski J
        Cardiorespiratory effects of low-flow and closed circuit inhalation anesthesia, using sevoflurane delivered with an in-circuit vaporizer and concentrations of compound A.
        Am J Vet Res. 1998; 59: 603-608
        • Murray JM
        • Renfrew CW
        • Bedi A
        • et al.
        Amsorb.
        Anesthesiology. 1999; 91: 1342-1348
        • Obata R
        • Bito H
        • Ohmura M
        • et al.
        The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function.
        Anesth Analg. 2000; 91: 1262-1268
        • Olson KN
        • Klein LV
        • Nann LE
        • et al.
        Closed-circuit liquid injection isoflurane anesthesia in the horse.
        Vet Surg. 1993; 22: 73-78
        • Simmons DH
        • Hemingway A
        Functional residual capacity and respiratory nitrogen excretion of dogs.
        J Appl Physiol. 1955; 8: 95-101
        • Stabernack CR
        • Brown R
        • Laster MJ
        • et al.
        Absorbents differ enormously in their capacity to produce compound A and carbon monoxide.
        Anesth Analg. 2000; 90: 1428-1435
        • Steffey EP
        Inhalational anesthetics.
        in: Thurmon JC Tranquilli WJ Benson GJ Lumb and Jones' Veterinary Anesthesia. 3rd edn. Williams & Wilkins, Baltimore, MD, USA1996: 297-329
        • Strum DP
        • Eger 2nd, EI
        Partition co-efficients for sevoflurane in human blood, saline and olive oil.
        Anesth Analg. 1987; 66: 654-657
        • Sun L
        • Suzuki Y
        • Takata M
        • et al.
        Repeated low-flow sevoflurane anesthesia: effects on hepatic and renal function in beagles.
        Masui. 1997; 46: 351-357
        • Thorpe CM
        • Kennedy RR
        Vaporization of isoflurane by liquid infusion.
        Anaesth Intens Care. 1994; 22: 380-382
        • Vermeulen PM
        • Kalkman CJ
        • Dirksen R
        • et al.
        Predictive performance of a physiological model for enflurane closed-circuit anaesthesia: effects of continuous cardiac output measurements and age-related solubility data.
        Br J Anaesth. 2002; 88: 38-45
        • Westenskow DR
        • Jordan WS
        • Hayes JK
        Uptake of enflurane: a study of the variability between subjects.
        Br J Anaesth. 1983; 55: 595-601
        • Wissing H
        • Kuhn I
        • Rietbock S
        • et al.
        Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane.
        Br J Anaesth. 2000; 84: 443-449
        • Yasuda N
        • Targ AG
        • Eger EI
        Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues.
        Anesth Analg. 1989; 69: 370-373